Global Injection And Infusion-based Drug Delivery Devices Market Size By Type (Auto Injection Systems, Cannula-Based Delivery Systems), By Application (Dental Clinic, Hospital), By Region, And Segment...

The Global Injection and Infusion-based Drug Delivery Devices Market was valued at USD 28.4 billion in 2023 and is projected to reach USD 52.7 billion by 2031, growing at a CAGR of 8.1% during the forecast period from 2023 to 2031. This growth is driven by the increasing prevalence of chronic diseases, rising demand for targeted and controlled drug delivery methods, and advancements in biologics and biosimilars. Injection and infusion-based delivery systems offer a precise, rapid, and efficient way to administer medications, particularly in oncology, diabetes, pain management, and autoimmune disorders.

Drivers:

1. Rising Burden of Chronic Diseases:

Chronic conditions like diabetes, cancer, and autoimmune disorders are witnessing a global surge. These diseases often require long-term and targeted therapies, propelling the adoption of injectable and infusion-based delivery methods for their effectiveness and patient compliance.

2. Technological Advancements in Drug Delivery:

Innovation in device design, such as wearable injectors, needle-free systems, and smart infusion pumps with integrated digital health tools, is enhancing patient experience, safety, and treatment adherence.

3. Growth in Biologics and Personalized Medicine:

Biologics and biosimilars are often administered through injection or infusion due to their molecular structure. The rising pipeline of such therapies supports the demand for sophisticated drug delivery devices.

Restraints:

1. High Cost of Advanced Devices:

The development and deployment of modern infusion systems and injectors involve high costs, which can be a barrier, especially in low-income healthcare settings.

2. Risk of Infections and Complications:

Poor handling or misuse of devices, particularly infusion systems, may lead to infections, device malfunction, or dosing errors, limiting broader adoption.

Opportunity:

1. Home Healthcare and Self-Administration Trends:

The shift towards home-based care and self-administration is creating lucrative opportunities for user-friendly, portable injection and infusion systems that reduce the need for hospital visits.

2. Expansion in Emerging Economies:

Rapid healthcare infrastructure development and increasing awareness in countries across Asia-Pacific and Latin America are opening new growth avenues for manufacturers of injection and infusion devices.

Market by System Type Insights:

The infusion pumps segment held the largest market share in 2023 due to its extensive use in hospital settings for chemotherapy, pain management, and parenteral nutrition. However, the wearable injectors segment is expected to grow at the fastest rate, driven by rising demand for patient-centric drug delivery and chronic disease management at home.

Market by End-use Insights:

In 2023, hospitals and clinics dominated the market due to high volumes of acute care and surgical procedures requiring precise drug administration. Meanwhile, the homecare segment is poised for robust growth, supported by the adoption of connected and automated drug delivery solutions that empower patients to manage their treatments independently.

Market by Regional Insights:

North America led the global market in 2023, driven by high healthcare spending, technological advancements, and a strong base of pharmaceutical and medical device companies. The Asia-Pacific region is forecast to grow the fastest, attributed to increasing healthcare awareness, investments in medical infrastructure, and a rising patient population with chronic diseases.

Competitive Scenario:

Key players in the market include Becton, Dickinson and Company, Baxter International Inc., Medtronic plc, Terumo Corporation, Fresenius Kabi, West Pharmaceutical Services, Ypsomed AG, and ICU Medical, Inc. These companies focus on product innovation, partnerships with pharmaceutical firms, and geographic expansion to strengthen their market positions.

Scope of Work – Global Injection and Infusion-based Drug Delivery Devices Market

Report Metric Details

Market Size (2023) USD 28.4 billion

Projected Market Size (2031) USD 52.7 billion

CAGR (2023–2031) 8.1%

Market Segments By System Type (Infusion Pumps, Auto-injectors, Prefilled Syringes, Wearable Injectors), By End-use (Hospitals & Clinics, Homecare, Ambulatory Surgical Centers), By Region

Growth Drivers Increasing chronic disease prevalence, technological advancements, rise of biologics

Opportunities Self-administration, home healthcare expansion, demand from emerging markets

Key Market Developments:

In 2023, Medtronic launched a new generation of smart infusion pumps integrated with real-time monitoring and wireless control features, improving patient safety and treatment outcomes.

In 2024, BD unveiled a wearable injector designed for subcutaneous biologic therapies, targeting improved usability and adherence.

In 2025, Baxter partnered with a digital therapeutics company to co-develop infusion systems integrated with mobile health platforms for personalized therapy tracking.

FAQs:

1) What is the current market size of the Global Injection and Infusion-based Drug Delivery Devices Market?

The market was valued at USD 28.4 billion in 2023.

2) What is the major growth driver of the Global Injection and Infusion-based Drug Delivery Devices Market?

The major driver is the increasing prevalence of chronic diseases and the need for effective, targeted drug delivery.

3) Which is the largest region during the forecast period in the Global Injection and Infusion-based Drug Delivery Devices Market?

North America held the largest market share in 2023.

4) Which segment accounted for the largest market share in the Global Injection and Infusion-based Drug Delivery Devices Market?

The infusion pumps segment held the largest market share in 2023.

5) Who are the key market players in the Global Injection and Infusion-based Drug Delivery Devices Market?

Key players include Becton Dickinson, Medtronic, Baxter International, Terumo, Fresenius Kabi, and ICU Medical.

Let me know if you’d like this as a downloadable file or need visual data summaries.